LIPID-METABOLISM EFFECTS WITH DESOGESTREL-CONTAINING ORAL-CONTRACEPTIVES

被引：16

作者：

BURKMAN, RT

机构：

[1] Department of Obstetrics and Gynecology, Henry Ford Hospital Detroit, MI

来源：

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 1993年 / 168卷 / 03期

关键词：

DESOGESTREL; LIPID METABOLISM; ORAL CONTRACEPTION; SELECTIVITY;

D O I：

10.1016/0002-9378(93)90334-F

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Desogestrel is a gonane progestogen that in early studies had an improved ratio between desired progestational effects and undesired androgenic effects. A review of more than 50 clinical studies suggests that desogestrel differs from progestins currently used in oral contraception in that it does not interfere with the estrogen effects on lipoprotein metabolism. This profile is attributable to the high selectivity of desogestrel.

引用

页码：1033 / 1040

页数：8

共 63 条

[1]

AGOESTINA T, 1987, 7TH C IND SOC OBST G, P70

[2]

ARAGONA C, 1984, CLIN EUR, V23, P511

[3]

BEIER S, 1987, GYNECOALOGICAL ENDOC, P477

[4] EFFECTS OF DESOGESTREL AND LEVONORGESTREL IN LOW-DOSE ESTROGEN ORAL-CONTRACEPTIVES ON SERUM-LIPOPROTEINS [J].